Skip to content
OpenSampling

2025 · Frontiers in medicine · open access

Considerations on the implementation of DCT: a SCAT-based analysis of fact-finding interviews in Europe and the United States, with implications for regions newly adopting DCT, including Japan

Taruno et al.

The finding, in our words

Interviews with clinical development staff found that decentralised clinical trials improved patient access by reducing travel burdens and waiting times. Implementation challenges included local regulations, telemedicine policies, IT infrastructure, information literacy and costs, with Japan lagging behind Europe and the United States in adoption.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2026

    This study validated a low-cost 3D-printed smartphone attachment and paper sensor for measuring glucose, uric acid and cholesterol in saliva, demonstrating high correlation with standard ELISA results in a small clinical cohort. The authors suggest this platform offers a scalable solution for decentralised diabetes management by balancing sensitivity with affordability.

    Nanostructured zinc-coordination supraparticles on cellulose fibers: A 3D-Printed μ-FAD integrated smartphone platform for multiplexed salivary metabolic monitoringYang et al., Biosensors & bioelectronics (paywalled) · source ↗

    • dct
    • economics
    • metabolome
    • self-collection
    • liquid
    • validation
    • saliva
  2. 2025

    An evaluation of blood sampling strategies across a large UK healthcare-worker cohort study, covering how sampling approach affected participation.

    Evaluating blood sampling strategies within the SIREN study: the experience from a large cohort of healthcare workers in the UKHettiarachchi et al., BMC Medical Research Methodology · source ↗

    • dct
    • acceptability
    • blood
    • economics
    • self-collection
    • capillary
    • validation
  3. 2024

    Decentralised recruitment channels generated 97.5% of enrolments, were cost effective, and met timelines, with 82.6% retention at six months, showing that decentralised strategies are feasible and conducive to achieving enrolment targets.

    Recruitment, Retention, and Participant Diversity in the Context of a Heart Failure Self-Care Digital Intervention Decentralized Clinical TrialWest et al., AMIA ... Annual Symposium proceedings. AMIA Symposium (paywalled) · source ↗

    • dct
    • economics
  4. 2024

    A digital decentralised clinical trial platform for long COVID successfully managed e-consent, randomisation, and data capture, but faced significant challenges including recruitment difficulties, imposter participants, and high attrition rates. These findings highlight critical considerations for designing viable remote trials in complex syndromes.

    Key considerations for digital decentralised clinical trials from a feasibility study assessing pacing interventions for long COVIDMcMullan et al., Scientific reports · source ↗

    • dct
    • economics
  5. 2024

    Interviews with European health technology assessment representatives showed that while decentralised clinical trial models offer real-world relevance and reduced recall bias, concerns persist regarding data quality when trial participants manage data collection independently.

    Opportunities and Challenges for Decentralized Clinical Trial Approaches: European Health Technology Assessment Perspectivede Jong et al., Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research (paywalled) · source ↗

    • dct
    • economics